Other languages Hikma Pharmaceuticals PLC

Equities

Market Closed - London S.E. Other stock markets 09:05:21 21/06/2024 pm IST			5-day change	1st Jan Change
1,971 ^GBX	-1.45%		+0.66%	+10.17%

20/06	Fitch Confirms Ratings, Outlook on Hikma Pharmaceuticals on 'Defensive Market Position'	MT
17/06	Transcript : Hikma Pharmaceuticals PLC, Xellia Pharmaceuticals ApS, Xellia Pharmaceuticals - M&A Call

Fitch Confirms Ratings, Outlook on Hikma Pharmaceuticals on 'Defensive Market Position'	20/06
Hikma adds scale to US injectables business with Xellia acquisition	17/06
Hikma to Buy Xellia Pharmaceuticals Assets for $135 Million	17/06
Astra gets US drug approval; Ascential trades in line	17/06
Morgan Stanley cuts Anglo American	11/06
Egypt, UAE talks continuing over Ras El Hekma land deal	29/05
HIKMA PHARMACEUTICALS : Time to capitalise on Hikma’s ongoing (share price) momentum	17/05
Jefferies cuts AJ Bell; Deutsche likes ConvaTec	03/05
HIKMA PHARMACEUTICALS : Hikma’s Q1 progress appreciated by the markets	26/04
Hikma Pharmaceuticals plc Approves Final Dividend, Payable on 3 May 2024	25/04
Hikma Pharmaceuticals backs outlook after making strong start to 2024	25/04
Hikma Pharmaceuticals Affirms FY24 Guidance	25/04
Hikma Pharmaceuticals PLC Proposes Final Dividend for the Full Year 2023	25/04
Hikma Pharmaceuticals plc Reiterates Earnings Guidance for the Year 2024	25/04
Hikma Pharmaceuticals PLC Announces Executive Changes	15/04
New Zealand Shares Close Flat on Monday; Fletcher Building Chair Steps Down	04/03
AFT Pharmaceuticals Limited Extends License for Maxigesic/Combogesic IV with Hikma Pharmaceuticals	04/03
Barclays cuts Direct Line to equal weight	29/02
Stocks called up following slew of FTSE 100 earnings	29/02
Hyloris Pharmaceuticals: le Maxigesic IV commercialisé aux Etats-unis	28/02

No results for this search

HIKMA PHARMACEUTICALS : Time to capitalise on Hikma’s ongoing (share price) momentum

May 17, 2024 at 06:40 pm IST